Maraviroc as possible treatment for PML-IRIS in natalizumab-treated patients with MS
Standard
Maraviroc as possible treatment for PML-IRIS in natalizumab-treated patients with MS. / Hodecker, Sibylle C; Stürner, Klarissa H; Becker, Veit; Elias-Hamp, Birte; Holst, Brigitte; Friese, Manuel A; Heesen, Christoph.
in: NEUROL-NEUROIMMUNOL, Jahrgang 4, Nr. 2, 03.2017, S. e325.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Maraviroc as possible treatment for PML-IRIS in natalizumab-treated patients with MS
AU - Hodecker, Sibylle C
AU - Stürner, Klarissa H
AU - Becker, Veit
AU - Elias-Hamp, Birte
AU - Holst, Brigitte
AU - Friese, Manuel A
AU - Heesen, Christoph
PY - 2017/3
Y1 - 2017/3
KW - Journal Article
U2 - 10.1212/NXI.0000000000000325
DO - 10.1212/NXI.0000000000000325
M3 - SCORING: Journal article
C2 - 28210661
VL - 4
SP - e325
JO - NEUROL-NEUROIMMUNOL
JF - NEUROL-NEUROIMMUNOL
SN - 2332-7812
IS - 2
ER -